In our highly digitized world, its past time we offer more frictionless and holistic patient experiences, especially for those dealing with such a stigmatized condition as obesity
Some studies suggest that GLP-1 receptor activation might influence sympathetic outflow, potentially affecting heart rate through autonomic pathways, though human data are mixed and largely inferential
How are you monitoring your patients
The ADAs new stepwise deintensification figure (Figure 13.2) and NICEs frailty prescribing algorithm give you a structured way to reduce treatment burden when the risks outweigh the benefits
Human drug compounding, Food and Drug Administration (2024) Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) FDA drug shortages: Semaglutide injection, Food and Drug Administration FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) Ozempic, DailyMed (2024) Find out if your insurance covers Ozempic, Novo Nordisk FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) Company statement: Novo Nordisk escalates legal actions to safeguard patients from potentially harmful compounded semaglutide drugs, Novo Nordisk (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
These symptoms should prompt immediate contact with your healthcare provider or call 911, not self-adjustment of medication doses
